.png)
Agenzia Italiana del Farmaco
Ricerca AIFA
List of titles Press releases
AIFA-EGUALIA Meeting. AIFA’s President Nisticò: “At work to ensure that all essential medicines are available to Italian patients”
“The fight against shortages also requires acknowledging the need to make many essential medicines economically sustainable. We have been working on this issue”.
Tue May 14 00:00:00 CEST 2024 Information and communication > Press releasesAIFA-Farmindustria meeting. AIFA’s President Nisticò: “Right away a technical committee to simplify procedures and halve the time for access to medicines”
“We are working to reduce the time of access procedures with a reduction of bureaucracy and with administrative simplification, ensuring that citizens may quickly use truly innovative medicines”, so AIFA’s President, Robert Nisticò at the end of the first meeting with the President of Farmindustria, Marcello Cattani. The meeting took place today at the headquarters of the Agency.
Thu May 09 00:00:00 CEST 2024 Information and communication > Press releasesAIFA Board of Directors meeting with the new President Robert Giovanni Nisticò Highlights News
The Board of Directors of the Italian Medicines Agency met today, convened and chaired by the new President Robert Giovanni Nisticò.
Wed Apr 17 00:00:00 CEST 2024 Information and communication > Press releasesAIFA's new Scientific and Economic Committee (CSE) takes office Highlights News
AIFA's new Scientific and Economic Committee for Medicines (CSE) took office yesterday, 26 March 2024.
Wed Mar 27 00:00:00 CET 2024 Information and communication > Press releasesAIFA's new Board of Directors takes office Highlights News
The new Board of Directors of the Italian Medicines Agency took office on Wednesday 20 March.
Thu Mar 21 00:00:00 CET 2024 Information and communication > Press releasesAIFA and Polo Strategico Nazionale: an important step towards the country’s digital future
An agreement was signed between the Italian Medicines Agency and PSN as part of Measure 1.1 ‘Digital Infrastructure’ of the RRP: an important project to foster innovation and digital transformation of data and application systems of AIFA.
Wed Dec 20 00:00:00 CET 2023 Information and communicationAIFA and FIMMG sign a Memorandum of Understanding Highlights News
Increasing the knowledge and involvement of General Practitioners (GPs) in the field of clinical research: this is the objective of the memorandum of understanding signed by the Italian Medicines Agency (AIFA) and the Italian Federation of General Practitioners (FIMMG).
Thu Sep 28 00:00:00 CEST 2023 Information and communication > Press releases“AIFA incontra”, a regulated system of transparent dialogue between the Agency and stakeholders kicks off Highlights News
The Chairman of the Board of Directors Giorgio Palù and the Interim DG Anna Rosa Marra presented the initiative at the AIFA headquarters.
Thu Sep 07 00:00:00 CEST 2023 Information and communication > Press releasesAIFA data on antivirals against COVID-19 in a study on 'Lancet' Highlights News
"This important study highlights how AIFA performs not only regulatory functions, but is also able to make a substantial contribution to the scientific community" underlines Giorgio Palù, President of the Management Board of AIFA.
Thu Jul 20 00:00:00 CEST 2023 Information and communication > Press releasesAIFA Board of Directors requests further information on the reimbursement of contraceptive pills Highlights News
The AIFA Board of Directors has noted that the Agency's Advisory Committees have not yet developed precise indications on the age groups to be granted the birth control pill free of charge, the distribution methods, and the costs for the National Health System in the various reimbursement cases.
Wed May 24 00:00:00 CEST 2023 Information and communication > Press releasesAIFA approves reimbursability of drugs for pre-exposure prophylaxis to HIV-1 (PrEP) Highlights News
An additional prevention tool for HIV-negative people with high-risk sexual behaviours.
Thu May 11 00:00:00 CEST 2023 Information and communication > Press releasesAIFA publishes the Report "The use of antibiotics in Italy - 2021" Highlights News
The Report "Antibiotic use in Italy - 2021" provides data and analysis on the trend in consumption and expenditure of antibiotics for human use in Italy.
Mon Apr 03 00:00:00 CEST 2023 Information and communication > Press releasesAIFA: Anna Rosa Marra appointed Interim Director General Highlights News
Anna Rosa Marra has been appointed Interim Director General of the Italian Medicines Agency by Decree of the Minister of Health.
Wed Jan 25 00:00:00 CET 2023 Information and communication > Press releasesSave the date - AIFA presenta le più recenti iniziative per ridurre la resistenza agli antibiotici in Italia
Domani, giovedì 19 gennaio 2023 alle 11:00, presso la sede dell’Agenzia. I giornalisti che volessero accreditarsi possono scrivere a ufficiostampaaifa@aifa.gov.it
Wed Jan 18 00:00:00 CET 2023 Information and communication > Press releasesAIFA launches an app for information and notifications on medicines Highlights News
The Italian Medicines Agency has released the AIFA Medicinali application for mobile devices, designed as a practical and immediate tool for accessing information and receiving notifications on medicines.
Fri Dec 02 00:00:00 CET 2022 Information and communication > Press releasesAntibiotici: giovedì 17 novembre conferenza stampa iniziative AIFA
Giovedì 17 novembre 2022 alle ore 12:00 si terrà presso la sede dell’Agenzia Italiana del Farmaco la conferenza stampa di presentazione della Settimana mondiale della consapevolezza antimicrobica.
Wed Nov 16 00:00:00 CET 2022 Information and communication > Press releasesThirteenth AIFA Report on the surveillance of anti-COVID-19 vaccines Highlights News
The data collected and analysed concern the reports of suspected adverse reactions registered in the National Pharmacovigilance Network between 27 December 2020 and 26 September 2022.
Thu Nov 03 00:00:00 CET 2022 Information and communication > Press releasesAIFA authorises Comirnaty Original bivalent vaccine for Sars-Cov-2 Omicron BA.4-5 variants Highlights News
On 14 September 2022 the AIFA Scientific-Technical Committee (CTS) decided to make available the use of the Comirnaty Original/Omicron BA.4-5 bivalent vaccine, approved by the EMA, as a booster dose for all people covered by the authorised indication.
Wed Sep 14 00:00:00 CEST 2022 Information and communication > Press releasesAIFA approves booster dose with Comirnaty and Spikevax bivalent vaccines Highlights News
On 5 September 2022, AIFA’s Scientific-Technical Committee (CTS) gave the green light to the use of the Comirnaty and Spikevax bivalent vaccines.
Mon Sep 05 00:00:00 CEST 2022 Information and communication > Press releasesAIFA authorises the therapeutic use of the monoclonal Evusheld for the early treatment of COVID-19 in subjects at risk of progression Highlights News
AIFA's Scientific Technical Committee (STC) has authorised the use of the monoclonal antibody Evusheld (tixagevimab and cilgavimab) in the early treatment of SARS-CoV-2 infected subjects at risk of a severe form of COVID-19.
Tue Aug 02 00:00:00 CEST 2022 Information and communication > Press releases2021 National Report on Medicines Use in Italy Highlights News
AIFA has published the 2021 National Report on Medicines Use in Italy, prepared by AIFA’s Medicines Utilisation Monitoring Centre (OsMed).
Fri Jul 29 00:00:00 CEST 2022 Information and communication > Press releasesTwelfth AIFA Report on the surveillance of anti-COVID-19 vaccines Highlights News
The data collected and analysed concern the reports of suspected adverse reactions registered in the National Pharmacovigilance Network between 27 December 2020 and 26 June 2022.
Wed Jul 27 00:00:00 CEST 2022 Information and communication > Press releasesPrescription of Paxlovid by the General Practitioner Highlights News
As of 21 April, general practitioners can also prescribe the antiviral medicine Paxlovid (based on nirmatrelvir/ritonavir) for the early treatment of coronavirus disease 2019 (COVID-19).
Wed Apr 20 00:00:00 CEST 2022 Information and communication > Press releasesEleventh AIFA Report on the surveillance of anti-COVID-19 vaccines Highlights News
Press release no 691 - The Italian Medicines Agency has published the eleventh Pharmacovigilance Report on anti-COVID-19 vaccines.
Tue Apr 19 00:00:00 CEST 2022 Information and communication > Press releasesAIFA: further investigations needed on second booster dose of COVID-19 vaccines Highlights News
AIFA's CTS started on 24th March 2022 the evaluation of the opportunity of a second booster dose of COVID-19 vaccines for particular categories of subjects.
Thu Mar 24 00:00:00 CET 2022 Information and communication > Press releases